Abstract
Uveitis is a sophisticated syndrome showing a high relevance with reactive oxygen species (ROS). Herein, an ROS-responsive PEGylated polypeptide based macromolecular prodrug of herbaceous antioxidant ethyl caffeate (EC) is designed via phenylboronic esters with improved solubility for the alleviation of uveitis. The antioxidative 4-hydroxybenzyl alcohol (HBA) and EC can be released from the macromolecular EC prodrug under the stimulation of ROS, which can effectively protect cells against oxidative stress-induced injury in an ROS-depletion way. The antioxidative and protective effects of the macromolecular EC prodrug in vivo are further verified in a uveitis mouse model. Overall, this work not only provides a handy method to synthesize a phenylboronic ester-bearing EC prodrug which is highly sensitive to pathological ROS, but also depicts a promising future to apply macromolecular antioxidative prodrugs in the treatment of uveitis as well as other ROS-related diseases.
Similar content being viewed by others
References
Lee, R. W.; Nicholson, L. B.; Sen, H. N.; Chan, C. C.; Wei, L.; Nussenblatt, R. B.; Dick, A. D. Autoimmune and autoinflammatory mechanisms in uveitis. Semin. Immunopathol. 2014, 36, 581–594.
Li, W.; He, B.; Dai, W.; Zhang, Q.; Liu, Y. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis. Int. Ophthalmol. 2014, 34, 465–476.
Mahran, A.; Ismail, S.; Allam, A. A. Development of triamcinolone acetonide-loaded microemulsion as a prospective ophthalmic delivery system for treatment of uveitis: in vitro and in vivo evaluation. Pharmaceutics 2021, 13, 444.
Shome, A.; Mugisho, O. O.; Niederer, R. L.; Rupenthal, I. D. Blocking the inflammasome: a novel approach to treat uveitis. Drug Discov. Today 2021, 26, 2839–2857.
Garg, V.; Nirmal, J.; Riadi, Y.; Kesharwani, P.; Kohli, K.; Jain, G. K. Amelioration of endotoxin-induced uveitis in rabbit by topical administration of tacrolimus proglycosome nano-vesicles. Pharm. Sci. 2021, 110, 871–875.
Ung, L.; Pattamatta, U.; Carnt, N.; Wilkinson-Berka, J. L.; Liew, G.; White, A. J. R. Oxidative stress and reactive oxygen species: a review of their role in ocular disease. Clin. Sci. 2017, 131, 2865–2883.
Xu, Q. Y.; Zhang, J.; Qin, T. Y.; Bao, J. Y.; Dong, H. T.; Zhou, X. R.; Hou, S. P.; Mao, L. M. The role of the inflammasomes in the pathogenesis of uveitis. Exp. Eye Res. 2021, 208, 108618.
Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11, 136–140.
Ahmad, A.; Ahsan, H. Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J. Immunoassay Immunochem. 2020, 41, 257–271.
Choulaki, C.; Papadaki, G.; Repa, A.; Kampouraki, E.; Kambas, K.; Ritis, K.; Bertsias, G.; Boumpas, D. T.; Sidiropoulos, P. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Res. Ther. 2015, 17, 257.
Ou, A. T.; Zhang, J. X.; Fang, Y. F.; Wang, R.; Tang, X. P.; Zhao, P. F.; Zhao, Y. G.; Zhang, M.; Huang, Y. Z. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases. Acta Pharmacol. Sin. 2021, 42, 1913–1920.
Mishra, S. R.; Mahapatra, K. K.; Behera, B. P.; Patra, S.; Bhol, C. S.; Panigrahi, D. P.; Praharaj, P. P.; Singh, A.; Patil, S.; Dhiman, R.; Bhutia, S. K. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int. J. Biochem. Cell Biol. 2021, 136, 106013.
van der Vliet, A.; Janssen-Heininger, Y. M. Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger. J. Cell. Biochem. 2014, 115, 427–435.
Halliwell, B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007, 35, 1147–1150.
Yadav, U. C. S.; Kalariya, N. M.; Ramana, K. V. Emerging role of antioxidants in the protection of uveitis complications. Curr. Med. Chem. 2011, 18, 931–942.
Li, Z.; Li, H.; Zhang, J.; Liu, X.; Gu, Z.; Li, Y. Ultrasmall nanoparticle ROS scavengers based on polyhedral oligomeric silsesquioxanes. Chinese J. Polym. Sci. 2020, 38, 1149–1156.
Granata, G.; Paterniti, I.; Geraci, C.; Cunsolo, F.; Esposito, E.; Cordaro, M.; Blanco, A. R.; Cuzzocrea, S.; Consoli, G. M. L. Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: enhanced drug solubility, stability, and anti-inflammatory effect. Mol. Pharm. 2017, 14, 1610–1622.
Deng, J.; Lin, D. Q.; Ding, X. Y.; Wang, Y.; Hu, Y. H.; Shi, H.; Chen, L.; Chu, B. Y.; Lei, L.; Wen, C. M.; Wang, J. Q.; Qian, Z. Y.; Li, X. Y. Multifunctional supramolecular filament hydrogel boosts anti-inflammatory efficacy in vitro and in vivo. Adv. Funct. Mater. 2022, 32, 2109173.
Masuda, T.; Yamada, K.; Akiyama, J.; Someya, T.; Odaka, Y.; Takeda, Y.; Tori, M.; Nakashima, K.; Maekawa, T.; Sone, Y. Antioxidation mechanism studies of caffeic acid: identification of antioxidation products of methyl caffeate from lipid oxidation. J. Agric. Food Chem. 2008, 56, 5947–5952.
Chiang, Y. M.; Lo, C. P.; Chen, Y. P.; Wang, S. Y.; Yang, N. S.; Kuo, Y. H.; Shyur, L. F. Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. Br. J. Pharmacol. 2005, 146, 352–363.
Mao, Y. W.; Tseng, H. W.; Liang, W. L.; Chen, I. S.; Chen, S. T.; Lee, M. H. Anti-inflammatory and free radial scavenging activities of the constituents isolated from Machilus zuihoensis. Molecules 2011, 16, 9451–9466.
Kularatne, R. N.; Bulumulla, C.; Catchpole, T.; Takacs, A.; Christie, A.; Stefan, M. C.; Csaky, K. G. Protection of human retinal pigment epithelial cells from oxidative damage using cysteine prodrugs. Free Radic. Biol. Med. 2020, 152, 386–394.
Muangnoi, C.; Phumsuay, R.; Jongjitphisut, N.; Waikasikorn, P.; Sangsawat, M.; Rashatasakhon, P.; Paraoan, L.; Rojsitthisak, P. Protective effects of a lutein ester prodrug, lutein diglutaric acid, against H2O2-induced oxidative stress in human retinal pigment epithelial cells. Int. J. Mol. Sci. 2021, 22, 4722.
Zhang, C.; Lu, H. Helical nonfouling polypeptides for biomedical applications. Chinese J. Polym. Sci. 2022, 40, 433–446.
Song, Z.; Han, Z.; Lv, S.; Chen, C.; Chen, L.; Yin, L.; Cheng, J. Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application. Chem. Soc. Rev. 2017, 46, 6570–6599.
Liu, Y.; Li, D.; Ding, J.; Chen, X. Controlled synthesis of polypeptides. Chin. Chem. Lett. 2020, 31, 3001–3014.
Ren, J.; Shu, X.; Wang, Y.; Wang, D.; Wu, G.; Zhang, X.; Jin, Q.; Liu, J.; Wu, Z.; Xu, Z.; Li, C. Z.; Li, H. Key progresses of MOE key laboratory of macromolecular synthesis and functionalization in 2020. Chin. Chem. Lett. 2022, 33, 1650–1658.
Xiong, R.; Xu, R. X.; Huang, C.; De Smedt, S.; Braeckmans, K. Stimuli-responsive nanobubbles for biomedical applications. Chem. Soc. Rev. 2021, 50, 5746–5776.
Han, H.; Hou, Y.; Chen, X.; Zhang, P.; Kang, M.; Jin, Q.; Ji, J.; Gao, M. Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy. J. Am. Chem. Soc. 2020, 142, 4944–4954.
Gao, Y.; Wang, J.; Chai, M.; Li, X.; Deng, Y.; Jin, Q.; Ji, J. Size and charge adaptive clustered nanoparticles targeting the biofilm microenvironment for chronic lung infection management. ACS Nano 2020, 14, 5686–5699.
Deng, Y.; Wang, Y.; Jia, F.; Liu, W.; Zhou, D.; Jin, Q.; Ji, J. Tailoring supramolecular prodrug nanoassemblies for reactive nitrogen species-potentiated chemotherapy of liver cancer. ACS Nano 2021, 15, 8663–8675.
Tao, W.; He, Z. ROS-responsive drug delivery systems for biomedical applications. Asian J. Pharm. Sci. 2018, 13, 101–112.
Xu, Q.; He, C.; Xiao, C.; Chen, X. Reactive oxygen species (ROS) responsive polymers for biomedical applications. Macromol. Biosci. 2016, 16, 635–646.
Broaders, K. E.; Grandhe, S.; Frechet, J. M. A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. J. Am. Chem. Soc. 2011, 133, 756–758.
Liu, D.; Cornel, E. J.; Du, J. Renoprotective angiographic polymersomes. Adv. Funct. Mater. 2020, 31, 2007330.
Tian, Z. Y.; Zhang, Z.; Wang, S.; Lu, H. A moisture-tolerant route to unprotected α/β-amino acid N-carboxyanhydrides and facile synthesis of hyperbranched polypeptides. Nat. Commun. 2021, 12, 5810.
Qiu, Y.; Shil, P. K.; Zhu, P.; Yang, H.; Verma, A.; Lei, B.; Li, Q. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice. Invest. Ophthalmol. Vis. Sci. 2014, 55, 3809–3818.
Yang, Z.; Min, Z.; Yu, B. Reactive oxygen species and immune regulation. Int. Rev. Immunol. 2020, 39, 292–298.
Weinstein, J. E.; Pepple, K. L. Cytokines in uveitis. Curr. Opin. Ophthalmol. 2018, 29, 267–274.
Yuan, H.; Xu, Y.; Luo, Y.; Wang, N. X.; Xiao, J. H. Role of Nrf2 in cell senescence regulation. Mol. Cell. Biochem. 2021, 476, 247–259.
Bao, M.; Liang, M.; Sun, X.; Mohyuddin, S. G.; Chen, S.; Wen, J.; Yong, Y.; Ma, X.; Yu, Z.; Ju, X.; Liu, X. Baicalin alleviates LPS-induced oxidative stress via NF-kappaB and Nrf2-HO1 signaling pathways in IPEC-J2 cells. Front. Vet. Sci. 2021, 8, 808233.
Acknowledgments
This work was financially supported by National Key Research and Development Project (No. 2020YFE0204400).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Notes
The authors declare no competing financial interest.
Electronic Supplementary Information
Rights and permissions
About this article
Cite this article
Li, YT., Sheng, ST., Yu, B. et al. An ROS-Responsive Antioxidative Macromolecular Prodrug of Caffeate for Uveitis Treatment. Chin J Polym Sci 40, 1101–1109 (2022). https://doi.org/10.1007/s10118-022-2798-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10118-022-2798-x